Literature DB >> 760195

Mammary cancer: selective action of the estrogen receptor complex.

M Ip, R J Milholland, F Rosen, U Kim.   

Abstract

Progesterone receptors in the autonomous rat mammary tumor MTW-9B are reduced 80 to 90 percent after ovariectomy, but are not reduced if ovariectomized animals are given estrogen. Tumor growth, however, is independent of estrogen status and insensitive to pharmacological doses of estradiol. This represents an unusual system characterized by a selective action of an inducing agent on the genome.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 760195     DOI: 10.1126/science.760195

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  7 in total

1.  Structural insights into selective agonist actions of tamoxifen on human estrogen receptor alpha.

Authors:  Sandipan Chakraborty; Pradip Kumar Biswas
Journal:  J Mol Model       Date:  2014-07-25       Impact factor: 1.810

Review 2.  Endocrine therapy of metastatic breast cancer.

Authors:  A Manni
Journal:  J Endocrinol Invest       Date:  1989-05       Impact factor: 4.256

3.  Estrogen responsive creatine kinase in human breast cancer cells.

Authors:  G Scambia; V Natoli; P B Panici; G Sica; S Mancuso
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

4.  Primary culture of normal rat mammary epithelial cells within a basement membrane matrix. I. Regulation of proliferation by hormones and growth factors.

Authors:  H A Hahm; M M Ip
Journal:  In Vitro Cell Dev Biol       Date:  1990-08

5.  Growth promoting influences of estradiol, epidermal growth factor, and insulin on human breast cancer: evidence for differential mechanism of action on tumor cells in vitro.

Authors:  S Iacobelli; C Natoli
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

6.  A cDNA for the estradiol-regulated 24K protein: control of mRNA levels in MCF-7 cells.

Authors:  I Moretti-Rojas; S A Fuqua; R A Montgomery; W L McGuire
Journal:  Breast Cancer Res Treat       Date:  1988-05       Impact factor: 4.872

7.  Case report: 16-yr life history and genomic evolution of an ER+ HER2- breast cancer.

Authors:  Bing Xu; Anu Amallraja; Padmapriya Swaminathan; Rachel Elsey; Christel Davis; Stephanie Theel; Sarah Viet; Jason Petersen; Amy Krie; Gareth Davies; Casey B Williams; Erik Ehli; Tobias Meißner
Journal:  Cold Spring Harb Mol Case Stud       Date:  2020-12-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.